Advertisement

Ashish Kacholia-Backed Company Announces 20% Interim Dividend After Strong Q3 Results


Updated: February 13, 2025 15:14

Image Source: The Economic Times

Stay Ahead – Explore Now! A Dose of Success: Marksans Pharma Receives UK Approval for Gabapentin Innovation

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement